Laser-assisted deep sclerectomy better than conventional type

Article

Erbium YAG-laser-assisted deep sclerectomy (DS) offers greatly simplified dissection and better long-term intraocular pressure (IOP) control compared with conventional DS.

Erbium YAG-laser-assisted deep sclerectomy (DS) offers greatly simplified dissection and better long-term intraocular pressure (IOP) control compared with conventional DS, concludes a study published in the March issue of Eye.

Thomas Klink and co-workers from Julius-Maximilians-University and St Vincentius Hospital, Germany examined the data of 14 consecutive patients (10 male, four female) who underwent surgery between 1999 and 2000. The procedure was begun as a standard DS. The deep corneoscleral lamella was dissected with a pulsed Erbium YAG laser (energy: 40-100 mJ, frequency: 5-10 Hz). Schlemm's canal was unroofed and the lamella thinned until aqueous percolated continuously through the membrane.

Mean preoperative IOP was 37.7±10.5 mmHg. The mean postoperative IOP was 16.1±3.9 mmHg at one month, 15.1±4.3 mmHg at three months, 16.4±4.5 mmHg at 12 months and 17.6±8.7 mmHg at 50.5 months. The complete success rates (IOP ≤21 mmHg + IOP reduction ≥ 20% without glaucoma medication) were 83.3% at three months and 50% at 12 and 50.5 months. Rates for qualified success (IOP ≤21 mmHg + IOP reduction ≥ 20% with glaucoma medication) were 91.7% at three months, 92.9% at 12 months and 78.6% 50.5 months. The number of glaucoma medications was reduced from 3.07±0.92 preoperatively to 1.14±1.1 at 50.5 months. The only intraoperative complication requiring iridectomy was a single case of anterior chamber penetration.

It was the conclusion of the authors that Erbium YAG-laser-assisted DS offers better long-term IOP control than standard DS.

Related Videos
Dr Nir Shoham Hazon, Director, Miramichi EyeNB Centre of Excellence, New Brunswick, Canada
Paul Harasymowycz, MD
Ms Neeru Vallabh on a virtual call with Ophthalmology Times Europe
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
© 2024 MJH Life Sciences

All rights reserved.